Tuberculosis News and Research

Latest Tuberculosis News and Research

Global Fund general manager appeals for donations, calling fund a 'good deal'

Gabriel Jaramillo, general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, "took a new approach to appealing for donations last week, arguing to finance ministers from participating nations that the fund is a great investment," the New York Times reports.

11 Jul 2012

New diagnostic test for drug-resistant TB allows 'new approach' to fight disease

The widespread incidence of drug-resistant tuberculosis (TB) "calls for a new approach to TB in the developing world," a Bloomberg editorial states.

11 Jul 2012

Activists criticize President Obama for not confirming attendance at AIDS 2012 conference

"Activists are reigniting their attacks against President Obama's record on battling AIDS ahead of the International AIDS Conference in Washington later this month," The Hill's "Global Affairs" blog reports.

11 Jul 2012

HIV and AIDS treatment: An interview with Charles Flexner, MD

The best estimates at the moment reckon that there are about 25 million people infected with HIV. Most of those are in resource-limited settings, including sub-Saharan Africa, South East Asia and India.

11 Jul 2012

DRCRF names 21 new Damon Runyon Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 21 new Damon Runyon Fellows at its spring Fellowship Award Committee review.

11 Jul 2012

Diabetes far more widespread than previously thought

A third of the world's human population is infected with a dormant tuberculosis bacteria, primarily people living in developing countries. The bacteria presents a lifelong TB risk. Recent research out of the University of Copenhagen demonstrates that the risk of tuberculosis breaking out is four times as likely if a person also suffers from diabetes. Meanwhile, as a diabetic, a person is five times as likely to die during tuberculosis treatment.

10 Jul 2012

Modest sums of U.S. foreign aid have saved lives on an 'unprecedented scale'

In this New York Times opinion piece, columnist Nicholas Kristof examines the effectiveness of U.S. foreign aid, writing, "In this election year in the United States, there'll be bitter debates about what should be cut from budgets, and one thing Democrats and Republicans seem to agree on is that foreign aid is bloated."

9 Jul 2012

International AIDS Conference a call for global solidarity

Noting the 2010 reversal of the HIV travel and immigration ban allowing the International AIDS Conference (AIDS 2012) to be held in the U.S. for the first time in more than 20 years, Rep. Barbara Lee (D-Calif.) writes in a Huffington Post Blog opinion piece, "It is so exciting to host this conference at such a pivotal time in the history of the AIDS response," and adds, "At no other time in history has our global leadership been more important than it is right now."

7 Jul 2012

Health gains in Rwanda illustrate value of universal health insurance

Noting that the Supreme Court last week upheld the constitutionality of the Affordable Care Act, "mov[ing] the United States closer to the goal of health coverage for all," Pulitzer Prize-winning author Tina Rosenberg reports on health care coverage in Rwanda in this post in the New York Times' "Opinionator" blog.

7 Jul 2012

New study maps global zoonotic disease 'hotspots'

"A global study mapping human diseases that come from animals like tuberculosis, AIDS, bird flu or Rift Valley fever has found that just 13 such diseases are responsible for 2.4 billion cases of human illness and 2.2 million deaths a year," Reuters reports.

6 Jul 2012

Study: 13 zoonoses responsible for 2.4B cases of human illness per year

A new global study mapping human-animal diseases like tuberculosis (TB) and Rift Valley fever finds that an "unlucky" 13 zoonoses are responsible for 2.4 billion cases of human illness and 2.2 million deaths per year. The vast majority occur in low- and middle-income countries.

5 Jul 2012

AIDS battle: stretching use of anti-HIV drugs

A Johns Hopkins expert in the drug treatment of HIV disease and AIDS is spearheading an international effort to radically shift the manufacturing and prescribing of combination therapies widely credited in the last decade for keeping the disease in check for 8 million of the 34 million infected people worldwide.

5 Jul 2012

New issue of 'Global Fund News Flash' available

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 5 of its newsletter, the "Global Fund News Flash."

4 Jul 2012

Johnson & Johnson seeking U.S. approval for first new TB drug in more than 4 decades

"Johnson & Johnson [J&J] said Monday that it is seeking U.S. approval for the first new type of medicine to fight deadly tuberculosis [TB] in more than four decades," the Associated Press reports, adding, "The experimental drug, called bedaquiline, also would be the first medicine specifically for treating multi-drug resistant tuberculosis."

4 Jul 2012

Indonesia must work to empower women in order to improve maternal health standards

Though Indonesia is "widely seen as a development success story -- indeed, it is sometimes referred to as one of Asia's 'rising powers' ... in the area of maternal health, the successes have been modest and much remains to be done," Andrew Rosser, associate director of the Indo-Pacific Governance Research Centre at the University of Adelaide, writes in an Inside Indonesia opinion piece.

4 Jul 2012

Janssen seeks accelerated FDA approval for bedaquiline to treat MDR-TB

Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.

2 Jul 2012

Gates Foundation plans to invest in biotech companies to improve global access to treatments, vaccines for infectious diseases

The Bill & Melinda Gates Foundation "plans to take equity stakes in up to a dozen biotech companies this year, signaling a shift towards a 'venture capital' approach at the world's biggest philanthropic organization" and "marking a further move away from its traditional approach of grant-giving and towards a more business-oriented way to support the development of treatments and vaccines for infectious diseases affecting the world's poor," the Financial Times reports.

29 Jun 2012

Inhibiting immune response during initial multi-drug therapy could speed TB treatment time

Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could - paradoxically - shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB Research.

29 Jun 2012

Miriam Hospital receives NIH renewal grant to support growth of Lifespan/Tufts/Brown CFAR

The Miriam Hospital has received an $8.5 million, five-year renewal grant from the National Institutes of Health (NIH) to support the continued growth of the Lifespan/Tufts/Brown Center for AIDS Research (CFAR).

28 Jun 2012

TB research finds body’s own response helps TB bacteria survive

Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children’s Center and the Center for TB Research. Shorter duration of drug therapy is key, researchers say, to increase treatment compliance for the growing global health threat posed by the disease.

28 Jun 2012